Nova Ltd. director Rani (Raanan) Cohen filed a Form 144 notice on November 10, 2026, disclosing a proposed sale of 3,121 ordinary shares with an aggregate market value of $1,040,042.04, to be executed on Nasdaq through Oppenheimer & Co. Inc.

Key Highlights

  • Seller and role: Rani (Raanan) Cohen, identified in the filing as a Director of Nova Ltd.
  • Shares proposed for sale: 3,121 ordinary shares with an aggregate market value of $1,040,042.04.
  • Shares outstanding: 31,780,111 ordinary shares outstanding at the time of the notice.
  • Approximate sale date: November 10, 2026, through Nasdaq via broker Oppenheimer & Co. Inc.
  • Trading plan: The sale is pursuant to a Rule 10b5-1 trading plan adopted on August 11, 2026.
  • No sales in prior 3 months: The filing reports nothing to report under securities sold during the past 3 months.

Nova Ltd. Director's Proposed Share Sale: Acquisition History and Plan Details

According to the Form 144 notice filed with the U.S. Securities and Exchange Commission, Rani (Raanan) Cohen, a director of Nova Ltd. (NASDAQ:NVMI), proposed to sell 3,121 ordinary shares of the company. The filing lists Oppenheimer & Co. Inc., located at 85 Broad St., New York, NY 10004, as the executing broker. The aggregate market value of the shares to be sold is stated as $1,040,042.04, against a total of 31,780,111 ordinary shares outstanding.

The filing details four separate tranches of shares underlying the proposed sale, each with a distinct acquisition history. Three shares were acquired on May 3, 2024, via cash payment upon exercise of employee stock options from Nova Ltd. An additional 665 shares were acquired on November 10, 2026, through a cashless (net) exercise of stock options. Two tranches of restricted stock units also contributed to the total: 639 shares issued upon vesting of RSUs on June 24, 2022, and 1,814 shares issued upon vesting of RSUs on June 23, 2023, both with no consideration paid, according to the filing.

The filing states that "the securities are being sold pursuant to a Rule 10b5-1 trading plan adopted on 08/11/2026." The notice was dated November 10, 2026, and signed by Yohanan Azriel as Authorized Signatory for Oppenheimer Israel, pursuant to delegation. The filing reports no securities sold by Cohen in the three months preceding the notice date.

What Was Disclosed

Nova Ltd. director Rani (Raanan) Cohen filed a Form 144 notice on November 10, 2026, proposing the sale of 3,121 ordinary shares valued at $1,040,042.04, acquired through stock option exercises and RSU vestings, under a Rule 10b5-1 plan adopted August 11, 2026.